CIALIS (tadalafil) Lilly Patent: 5,859,006 Expiration: Nov 21, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post D…
Drug Patent Expirations for the Week of November 19, 2017 Read Post »
Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent expiration for Mallinckrodt Hosp drug INOMAX …
New patent expiration for Mallinckrodt Hosp drug INOMAX Read Post »
Annual Drug Patent Expirations for INVANZ Invanz is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Merck Sharp drug INVANZ appeared first on Dru…
New patent expiration for Merck Sharp drug INVANZ Read Post »
Annual Drug Patent Expirations for STARLIX Starlix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Novartis drug STARLIX appeared …
Annual Drug Patent Expirations for PRELAY Prelay is a drug marketed by Sankyo and is included in one NDA. There are two patents protecting this drug. This drug has forty-five…
The post New patent expiration for Sankyo drug PRELAY appeared first o…
INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …
Drug Patent Expirations for the Week of November 12, 2017 Read Post »
INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …
Drug Patent Expirations for the Week of November 12, 2017 Read Post »
Annual Drug Patent Expirations for INVEGA+SUSTENNA Invega Sustenna is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Janssen Pharms drug INVEGA …
New patent expiration for Janssen Pharms drug INVEGA SUSTENNA Read Post »
Annual Drug Patent Expirations for ORBACTIV Orbactiv is a drug marketed by The Medicines Co and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for The Medicines drug ORBACTIV appeared fir…
New patent expiration for The Medicines drug ORBACTIV Read Post »
Annual Drug Patent Expirations for INVEGA+TRINZA Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug INVEGA TRINZA …
New patent expiration for Janssen Pharms drug INVEGA TRINZA Read Post »